Find a Doctor

Dr. Arne Ohlsson

University Of Toronto

Bio


Arne Ohlsson is in Toronto, Canada. Dr. Ohlsson is a global expert in Patent Ductus Arteriosus. They have been an author on 152 peer reviewed articles in the past 15 years. In particular, they have been an author on 26 peer reviewed articles regarding Patent Ductus Arteriosus. Dr. Ohlsson's top three areas of expertise are Patent Ductus Arteriosus, Premature Infant, Periventricular Leukomalacia, and Necrotizing Enterocolitis.

Contact

600 University Avenue, M5g 1x5
Toronto, ON, CA

Latest Advances


  • Condition: Preterm and/or Low Birth Weight (LBW) Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Early versus Late Erythropoietin
  • Number of Patients: 0
  • Published —
The study compared the outcomes between early versus late erythropoietin for preterm and/or low birth weight infants.
  • Condition: Preterm or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Early Erythropoiesis-Stimulating Agents (ESAs)
  • Number of Patients: 0
  • Published —
This review of the literature assessed the safety and effectiveness of the use of erythropoiesis-stimulating agents (ESAs) in preterm and/or low birth weight infants.
  • Condition: Infection in Preterm and/or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Intravenous Immunoglobulin
  • Number of Patients: 5000
  • Published —
The study researched the use of intravenous immunoglobulin in preventing infection in preterm and/or low birth weight infants.
  • Condition: Anemia in Preterm Or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Erythropoiesis-stimulating Agents
  • Number of Patients: 1651
  • Published —
In this study, researchers evaluated the safety and effectiveness of erythropoiesis-stimulating agents for the treatment of anemia in preterm or low birth weight infants.
  • Condition: Pain in Newborns
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Acetaminophen
  • Number of Patients: 728
  • Published —
In this study, researchers evaluated the safety and effectiveness of acetaminophen for the prevention or treatment of pain in newborns.
  • Condition: Patent Ductus Arteriosus with Preterm and/or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Ibuprofen
  • Number of Patients: 1070
  • Published —
This study tested the safety and efficacy of using ibuprofen to treat preterm and/or low birth weight infants with patent ductus arteriosus.
  • Condition: Preterm infants at risk for or having respiratory distress syndrome
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Inositol
  • Number of Patients: 1177
  • Published —
The objective of the study was to assess the effectiveness and safety of inositol in preterm infants with or without respiratory distress syndrome (RDS) in reducing adverse neonatal outcomes.
  • Condition: Prevention of Patent Ductus Arteriosus (PDA) in Preterm and/or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Ibuprofen
  • Number of Patients: 0
  • Published —
This review of the literature determined the effectiveness and safety of ibuprofen compared to placebo/no intervention, or other cyclo-oxygenase inhibitor drugs in the prevention of patent ductus arteriosus (hole in heart; PDA) in preterm infants.
  • Condition: Preterm or Low Birth Weight Infants
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Late Erythropoiesis-Stimulating Agents (ESAs): Darbepoetin (Darbe) and EPO
  • Number of Patients: 1651
  • Published —
This review of the literature assessed the effectiveness and safety of late initiation of erythropoiesis-stimulating agents (ESAs), between eight and 28 days after birth, in reducing the use of red blood cell (RBC) transfusions in preterm or low birth weight infants.

Clinical Trials


All Publications
View All


  • Journal: The Cochrane database of systematic reviews
  • Published —
Early erythropoiesis-stimulating agents in preterm or low birth weight infants.
  • Journal: The Cochrane database of systematic reviews
  • Published —
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

Contact

600 University Avenue, M5g 1x5
Toronto, ON, CA

Insurance

Contact them to find out if they accept your insurance plan.